Emory University
Clinical trials sponsored by Emory University, explained in plain language.
-
Custom-Made vaccine takes on tough breast cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study tests a personalized vaccine made from a patient's own tumor, combined with immunotherapy drugs, for triple negative breast cancer. The goal is to see if the vaccine is safe and can help the immune system attack cancer cells. About 18 adults with various st…
Phase: PHASE1 • Sponsor: Emory University • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 07:08 UTC
-
Can a single booster keep meningitis b at bay?
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at whether a single booster dose of a meningitis B vaccine can protect young adults who got a different meningitis B vaccine at least 2.5 years ago. Researchers will measure immune responses in 125 healthy participants before and after the booster. The goal is to…
Phase: PHASE4 • Sponsor: Emory University • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:52 UTC
-
New hope for rare bleeding disorder: experimental drug aims to stop bleeding episodes
Disease control Recruiting nowThis study tests an investigational drug called eptacog beta for people with Glanzmann thrombasthenia, a rare inherited bleeding disorder. Over 9 months, about 6 participants will use the drug to treat serious bleeding episodes, with an optional extension to see if regular infusi…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:08 UTC
-
New hope for advanced lung cancer: drug combo trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug (MRX-2843) combined with a standard treatment (osimertinib) for people with advanced EGFR-mutant non-small cell lung cancer. The goal is to find the safest and most effective dose and to see how well the combination works. About 69 particip…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:08 UTC
-
Brain bleed breakthrough? new study tests if early surgery saves lives
Disease control Recruiting nowThis study looks at whether doing a small surgery early to remove blood from a deep brain bleed helps patients more than standard medical care. Standard care includes ICU monitoring and blood pressure control. The study will enroll 600 adults aged 18-70 with a specific type of br…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:07 UTC
-
New hope for hard-to-treat bone cancer? experimental drug combo enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called tegavivint combined with the chemotherapy gemcitabine in people whose osteosarcoma (a type of bone cancer) has returned or not responded to standard treatments. The main goal is to find the safest dose of tegavivint when given with g…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:06 UTC
-
New cocktail aims to stop High-Risk myeloma from coming back
Disease control Recruiting nowThis study tests whether a combination of three drugs—belantamab, pomalidomide, and dexamethasone—can keep high-risk multiple myeloma from returning after a stem cell transplant. About 34 adults who have already had a transplant and are in partial remission or better will take th…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:06 UTC
-
Could a painkiller boost immunotherapy in liver cancer?
Disease control Recruiting nowThis study tests whether adding celecoxib (a painkiller) to standard immunotherapy drugs (durvalumab and tremelimumab) can help control advanced liver cancer that has spread. About 39 adults with advanced or metastatic hepatocellular carcinoma will receive the combination. The go…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:06 UTC
-
Could a pneumonia drug beat back resistant ovarian cancer?
Disease control Recruiting nowThis study tests whether atovaquone, a drug normally used for infections, can help people with a type of ovarian cancer that no longer responds to standard platinum chemotherapy. About 28 adults with platinum-resistant high-grade serous ovarian cancer will take atovaquone. The go…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:05 UTC
-
New study tests safer bleeding control for hemophilia a patients on emicizumab
Disease control Recruiting nowThis study looks at whether a low, personalized dose of aPCC (FEIBA) is safe and helps control bleeding in children and adults with hemophilia A who have inhibitors and are already taking emicizumab. Researchers will measure how well the blood clots after the dose and watch for s…
Phase: PHASE3 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:05 UTC
-
Mindfulness and nerve zapping show promise for kidney patients
Disease control Recruiting nowThis study looks at whether mindfulness meditation can improve nerve function in people with chronic kidney disease (CKD). It also tests if a gentle nerve stimulation device can boost the benefits. The study involves 150 adults with moderate CKD and measures changes in nerve acti…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:05 UTC
-
Digital nudge aims to boost life-saving heart failure drug use in 4,000 patients
Disease control Recruiting nowThis study tests whether simple digital checklists and reminders can help doctors prescribe the best combination of heart failure medications to more patients. Researchers will enroll 4,000 adults with heart failure and a weak heart pump. The goal is to see if these tools increas…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:03 UTC
-
Precision proton beam aims to stop lung cancer return after surgery
Disease control Recruiting nowThis study tests whether proton beam radiation, a precise type of radiation that spares healthy tissue, can reduce the risk of cancer returning in people with non-small cell lung cancer that has spread to chest lymph nodes. Participants have already had surgery and chemotherapy. …
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:02 UTC
-
Cholesterol drug boosts immunotherapy against tough head and neck cancers
Disease control Recruiting nowThis study tests whether adding a common cholesterol-lowering drug (lovastatin) to an immunotherapy (pembrolizumab) can help shrink tumors in people with head and neck cancer that has returned or spread. About 28 adults whose cancer has not responded to prior treatments will rece…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:01 UTC
-
Can a 'Poop Pill' stop superbugs in their tracks?
Disease control Recruiting nowThis study tests whether a microbiome therapy (like a fecal transplant) can safely reduce antibiotic-resistant bacteria living in the gut of hospitalized patients. About 40 adults who carry these superbugs will receive either the therapy or a placebo. The goal is to lower the amo…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:00 UTC
-
Immune cell army targets childhood cancers in new trial
Disease control Recruiting nowThis early-phase study tests a new treatment for children whose neuroblastoma or osteosarcoma has not responded to standard therapy or has returned. The approach combines specially grown immune cells (gamma delta T cells) from a healthy donor with several chemotherapy drugs and a…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
Poison center doctors help rural ERs fight opioid crisis
Disease control Recruiting nowThis study aims to make opioid use disorder treatment more available in rural Georgia by connecting emergency room patients with medical toxicologists at the Georgia Poison Center through video calls. About 480 adults who come to the ER with opioid withdrawal, overdose, or seekin…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
New proton therapy aims to cut side effects in prostate cancer treatment
Disease control Recruiting nowThis study tests a precise type of radiation called proton therapy for men with high-risk prostate cancer that has spread to lymph nodes. The goal is to see if targeting the tumor and nearby lymph nodes causes fewer bowel and bladder side effects than standard radiation. About 30…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:58 UTC
-
Experimental combo aims to rev up immune system against lung cancer
Disease control Recruiting nowThis early-phase study tests whether adding low-dose IL-2 to the immunotherapy drug pembrolizumab can strengthen the immune system's attack on advanced lung cancer. About 15 people with untreated stage IV non-small cell lung cancer will receive the combination. The main goal is t…
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:58 UTC
-
New chemo cocktail aims to shrink pancreatic tumors before surgery
Disease control Recruiting nowThis study tests whether giving a combination of three chemotherapy drugs (gemcitabine, cisplatin, and nab-paclitaxel) before surgery can help shrink pancreatic tumors and improve outcomes. It is for people with pancreatic cancer that can be removed or is borderline removable. Th…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
Common painkiller may help immunotherapy fight lung cancer
Disease control Recruiting nowThis study tests whether adding diclofenac, a common anti-inflammatory painkiller, can help control tumor growth in people with advanced lung cancer whose disease is starting to worsen on immunotherapy alone. About 20 adults with stage III or IV non-small cell lung cancer will re…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
Gut bacteria therapy takes on superbugs in new trial
Disease control Recruiting nowThis study tests whether a treatment made from healthy gut bacteria (microbiota therapy) can safely reduce the amount of drug-resistant germs living in the gut. About 60 adults who carry these superbugs will either get the treatment or be observed. The goal is to see if the thera…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
Could baby cells heal young hearts? new trial launches
Disease control Recruiting nowThis early-stage study tests whether infusions of special cells from donated umbilical cords (neonatal mesenchymal cells) are safe for people aged 4 to 29 with dilated cardiomyopathy, a condition where the heart is enlarged and weak. The goal is to see if these cells can improve …
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
Morning may matter: new trial tests timing of immunotherapy for melanoma
Disease control Recruiting nowThis study is for people with advanced melanoma that has spread or cannot be removed by surgery. It tests whether giving two immunotherapy drugs (ipilimumab and nivolumab) in the morning works better than giving them later in the day. The goal is to see if timing can improve how …
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:49 UTC
-
New drug cocktail shows promise for tough bladder cancer
Disease control Recruiting nowThis early-phase study tests a combination of two drugs—cabozantinib and enfortumab vedotin—in people with advanced bladder cancer that has spread or cannot be removed. The goal is to find the best dose and see if the combo is safe and shrinks tumors. About 32 adults who have alr…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Baby eye test could spot autism before first birthday
Diagnosis Recruiting nowThis study is testing whether a quick, non-invasive eye-tracking test can help screen for autism spectrum disorder (ASD) and other developmental delays in babies as young as 9 months old. Researchers will use a mobile device to measure how infants look at social scenes, then foll…
Sponsor: Emory University • Aim: Diagnosis
Last updated May 26, 2026 06:49 UTC
-
Video games may combat loneliness in seniors with memory loss
Symptom relief Recruiting nowThis study tests whether playing online games with others can reduce loneliness and improve social connections in older adults, including those with mild cognitive impairment (MCI). Researchers will measure changes in feelings of isolation, loneliness, and quality of life. The go…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:08 UTC
-
Could a Parkinson's drug help treat Depression-Related anhedonia?
Symptom relief Recruiting nowThis study tests whether L-DOPA, a drug used for Parkinson's disease, can improve loss of interest and pleasure (anhedonia) in people with depression who also have high inflammation. Seventy adults aged 25-55 will receive either L-DOPA or a placebo for 8 weeks. Researchers will m…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:07 UTC
-
No-Opioid pain control put to the test in major surgery trial
Symptom relief Recruiting nowThis study compares a pain management plan that avoids opioids to one that includes them, for people having joint replacement or other orthopedic surgeries. About 80 adults will be randomly assigned to one of two groups and report their pain levels for 14 days after surgery. The …
Phase: PHASE3 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:06 UTC
-
Sleep therapy may boost blood sugar control in type 1 diabetes
Symptom relief Recruiting nowThis study tests a 12-week sleep improvement program for adults aged 18-40 with type 1 diabetes. The goal is to see if better sleep helps with blood sugar control and reduces diabetes-related distress. 300 participants will be followed for 9 months.
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:06 UTC
-
Shoulder surgery showdown: to cut or not to cut a chest muscle?
Symptom relief Recruiting nowThis study looks at whether releasing a small chest muscle (pectoralis minor) during reverse shoulder replacement helps reduce pain and improve movement. About 90 adults getting this surgery will be randomly assigned to have the muscle released or not. Researchers will track pain…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:06 UTC
-
New program aims to speed up healing of diabetic foot sores
Symptom relief Recruiting nowThis study tests a program called CARE-D-Foot-Nav, which assigns a patient navigator to help adults with diabetes and foot ulcers manage their care. The goal is to see if this extra support leads to more ulcers healing completely within 20 weeks compared to usual care. The study …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:05 UTC
-
Could an arthritis drug lift the fog of depression?
Symptom relief Recruiting nowThis study tests whether baricitinib, a drug that blocks JAK signaling, can improve motivation and brain function in people with major depression who have high inflammation. About 100 adults aged 25-55 with depression and elevated C-reactive protein will receive the drug or place…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:05 UTC
-
Teens with IBD get a high-tech stress fix: biofeedback meets coping skills
Symptom relief Recruiting nowThis study tests a virtual group program that teaches teens with inflammatory bowel disease (IBD) coping skills and uses heart rate biofeedback to help manage stress. About 128 teens aged 13-18 will either join the program right away or be placed on a waitlist. The goal is to see…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:05 UTC
-
New study tests if body awareness can heal dissociation
Symptom relief Recruiting nowThis study tests whether body-focused and non-body-focused interventions can reduce symptoms of dissociation in people who have experienced trauma. Researchers will enroll 350 participants at Emory University and the University of Pittsburgh. They will measure changes in brain ne…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:05 UTC
-
Family-Inclusive online rehab aims to boost stroke recovery at home
Symptom relief Recruiting nowThis study tests a web-based rehab program for stroke survivors and their care partners (family members). The program focuses on problem-solving and arm exercises at home to improve the survivor's arm use and social participation while also supporting the caregiver's well-being. …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:05 UTC
-
Slow drip may save nerves: new trial for cancer patients
Symptom relief Recruiting nowThis study compares giving the chemotherapy drug oxaliplatin over 2 hours versus 6 hours to see if the longer infusion reduces nerve damage. About 60 people with gastrointestinal cancers who are scheduled for at least 4 cycles of FOLFOX6 chemotherapy will participate. The goal is…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:04 UTC
-
New tool aims to remove travel hurdles for cancer patients getting radiation
Symptom relief Recruiting nowThis study tests a program called TRACT that helps cancer patients find transportation to their radiation treatments. Many patients miss or delay care due to travel problems, which can affect their health. The program will be offered to 76 adults with solid tumors who are getting…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:03 UTC
-
Could MDMA boost PTSD therapy? new trial aims to find out
Symptom relief Recruiting nowThis study tests whether a single dose of MDMA, given alongside two weeks of intensive exposure therapy, can help adults with PTSD feel better faster and longer. About 200 participants will receive either MDMA or a placebo during therapy. The main goal is to see if the combinatio…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:03 UTC
-
Veterans' chronic pain targeted by At-Home brain zaps
Symptom relief Recruiting nowThis study tests if a safe, non-invasive brain stimulation technique called tDCS can reduce chronic pain in military veterans. About 100 veterans receiving care at Emory Healthcare will use a headset at home to deliver mild electrical currents to the brain. The goal is to see if …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:01 UTC
-
Steroid pack may cut opioid need after foot surgery
Symptom relief Recruiting nowThis study tests whether a 6-day low-dose steroid (Medrol Dosepak) can reduce pain, nausea, and the need for opioid painkillers in 180 adults having foot or ankle surgery. Participants will report their pain and nausea levels, and researchers will track how many opioids they use.…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 07:00 UTC
-
Could a tiny dose of naltrexone relieve HIV nerve pain without opioids?
Symptom relief Recruiting nowThis study tests whether a very low dose of naltrexone, a drug usually used for addiction, can reduce chronic nerve pain in people with HIV. Researchers will enroll 60 adults with HIV and neuropathic pain to take the drug for 12 weeks and report their pain levels. The goal is to …
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 06:59 UTC
-
Beat the clock: music may boost exercise and brain health in seniors
Symptom relief Recruiting nowThis study tests whether exercising to beat-accented music helps older adults with memory concerns stay active and improve thinking skills. Eighty participants aged 65+ will do strength and aerobic training for 6 months, some with music and some without. Researchers will track ph…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 06:58 UTC
-
New painkiller may reduce opioid use after ankle surgery
Symptom relief Recruiting nowThis study compares two numbing medications, EXPAREL and bupivacaine, injected near the nerves around the ankle before total ankle replacement surgery. The goal is to see which provides better pain control and reduces the need for opioid painkillers afterward. About 104 adults ha…
Phase: PHASE3 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 06:52 UTC
-
Can a new way of delivering voice therapy help people speak more clearly?
Symptom relief Recruiting nowThis study looks at how different ways of giving voice therapy affect speaking ability over 12 months. It includes 120 adults with voice problems like muscle tension dysphonia or vocal fold lesions. Participants will receive behavioral voice therapy and be monitored through surve…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 06:51 UTC
-
New combo therapy aims to ease symptoms in advanced lung cancer
Symptom relief Recruiting nowThis early-stage study tests whether giving palliative radiotherapy together with the drug lurbinectedin is safe for people with extensive-stage small cell lung cancer that has spread beyond the chest. The goal is to relieve symptoms caused by the cancer. About 22 adults whose ca…
Phase: PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 06:51 UTC
-
New online tool aims to ease cancer's hidden toll on patients and families
Symptom relief Recruiting nowThis study tests a web-based program for colorectal cancer patients on chemotherapy and their caregivers. The program targets common symptoms like fatigue, depression, sleep problems, pain, and brain fog. Researchers want to see if it's easy to use and helps improve quality of li…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 06:50 UTC
-
Online exercise program aims to boost recovery in young transplant patients
Symptom relief Recruiting nowThis study tests whether a 12-week virtual physical therapy program is practical and helpful for children and young adults (ages 8-23) who are at least 100 days past a bone marrow transplant. Participants will have twice-weekly online sessions with a physical therapist and receiv…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 06:48 UTC
-
Can tapering steroids after brain surgery reduce side effects?
Symptom relief Recruiting nowThis study looks at whether slowly lowering the dose of the steroid dexamethasone after brain tumor surgery can reduce side effects like high blood sugar and high blood pressure, while still preventing brain swelling. About 200 adults with certain brain tumors will be enrolled. T…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 06:48 UTC
-
Could extra steroids after scoliosis surgery cut pain and hospital time?
Symptom relief Recruiting nowThis study looks at whether giving extra doses of a steroid called dexamethasone after scoliosis surgery can help teens recover better. About 50 participants aged 10-18 will either get the standard one dose or three extra doses after surgery. Researchers will measure pain, nausea…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 04:38 UTC
-
Mind over injury: new study tests mindfulness for athlete recovery
Symptom relief Recruiting nowThis study looks at whether mindfulness training can improve recovery for college athletes who need surgery for sports injuries. About 40 student-athletes will either get mindfulness training or standard care. Researchers will track pain, physical function, and mental health for …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 04:38 UTC
-
Can stress harm your heart? new study investigates in women with chest pain
Knowledge-focused Recruiting nowThis study looks at how mental stress impacts the heart and blood vessels in postmenopausal women with coronary microvascular dysfunction (CMD), a condition where the heart's tiny arteries don't work properly, causing chest pain. Researchers will compare stress responses in women…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:08 UTC
-
PKU protein puzzle: study seeks answers for adults
Knowledge-focused Recruiting nowThis study aims to find out how much protein adults with Phenylketonuria (PKU) need, based on their genetics and the special medical foods they eat. Researchers will measure how the body processes a harmless tracer in 18 participants. The goal is to better understand protein need…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:08 UTC
-
Can a common antibiotic tame inflammation and change gut bacteria?
Knowledge-focused Recruiting nowThis study looks at how the antibiotic doxycycline affects inflammation and the natural bacteria living in the body. Researchers will study 200 people with HIV or on HIV prevention medication (PrEP). The goal is to understand if doxycycline has extra effects beyond fighting infec…
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:07 UTC
-
Veterans' PTSD study targets hidden heart danger
Knowledge-focused Recruiting nowThis study looks at why people with PTSD often have higher heart disease risk. Researchers will test two daily therapies—deep breathing exercises and a mild nerve-stimulating device—to see if they can calm an overactive nervous system. About 120 veterans with or without PTSD and …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:07 UTC
-
Can compassion training cure burnout in cancer care teams?
Knowledge-focused Recruiting nowThis study tests a new program called Compassion-Centered Spiritual Health Interventions for Teams (CCSH-TI) for hospital staff and providers. About 80 employees from a cancer center will be randomly assigned to either the program or their usual routine. The goal is to see if the…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:06 UTC
-
Forgetting fear: new study aims to erase traumatic memories before they stick
Knowledge-focused Recruiting nowThis study explores a non-invasive way to weaken fear memories soon after a traumatic event, potentially lowering the risk of developing PTSD. Researchers will use brain imaging and mild sensory stimulation in 66 adults (some with PTSD) to see if they can disrupt how the brain st…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:06 UTC
-
Rural women get boost in cancer screening through family history program
Knowledge-focused Recruiting nowThis study looks at whether a family history screening program can help more women in rural Georgia get tested for BRCA gene mutations linked to breast and ovarian cancer. About 3,200 women from public health clinics will take part. The goal is to see if the program increases the…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:04 UTC
-
New study tracks kids at high genetic risk for cancer to catch it early
Knowledge-focused Recruiting nowThis study follows children under 21 who have a genetic condition that raises their risk of developing cancer, along with their relatives. Researchers will collect medical information and samples over time to better understand how these cancers develop and how to spot them early.…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:03 UTC
-
Sticky patch hears swallowing problems in stroke patients
Knowledge-focused Recruiting nowThis study is testing a new, non-invasive wearable patch with a microphone that listens to swallowing sounds in people who have trouble swallowing after a stroke. Researchers will collect these sounds during a standard swallowing X-ray test and use machine learning to find patter…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:03 UTC
-
New study aims to uncover triggers of suicide in bipolar patients
Knowledge-focused Recruiting nowThis study looks at why people with bipolar disorder may think about or attempt suicide, focusing on life experiences and biology. Researchers will test a 6-week group program to help reduce suicidal thoughts and improve quality of life. About 130 English-speaking adults with bip…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:03 UTC
-
Tailored care plans aim to close health literacy gap for black prostate cancer survivors
Knowledge-focused Recruiting nowThis study compares a standard survivorship care plan to one that is simplified for people with lower health literacy. Researchers want to see if the tailored plan helps African American prostate cancer patients better understand their treatment side effects and follow-up needs. …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:02 UTC
-
Atlanta study aims to strengthen mental health in ethiopian and eritrean youth
Knowledge-focused Recruiting nowThis study tests a group program called Weyera to see if it helps Ethiopian and Eritrean young adults (ages 18-29) in Atlanta build resilience and improve mental health. Researchers want to know if the program is acceptable, safe, and practical to run. The study will track how ma…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 07:01 UTC
-
Can better conversations about immunotherapy help patients?
Knowledge-focused Recruiting nowThis study looks at how cancer patients and their doctors discuss immunotherapy. Researchers want to understand where patients get information, what they know, and how doctors explain the treatment. They will also test if educational videos can improve patient understanding. The …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:59 UTC
-
New study tracks immune signals in breast cancer patients
Knowledge-focused Recruiting nowThis study looks at how the immune system responds in people with early-stage triple negative breast cancer who are receiving standard chemotherapy combined with immunotherapy (pembrolizumab). Researchers will measure certain immune markers in the blood and tumor tissue to see if…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:58 UTC
-
New study aims to unlock secrets of swallowing disorder
Knowledge-focused Recruiting nowThis study looks at muscle scarring in the esophagus of people with achalasia, a swallowing disorder. Researchers want to see how scarring relates to muscle function tests. The goal is to understand the disease better so doctors can treat it earlier. About 80 adults with achalasi…
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:53 UTC
-
Can prism glasses and mild zaps help stroke survivors see straight and walk better?
Knowledge-focused Recruiting nowThis study looks at whether combining prism adaptation training with electrical stimulation can help people who have had a stroke and have spatial neglect (trouble noticing things on one side). Researchers will measure changes in pointing, brain activity, and walking. The study i…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:52 UTC
-
New study aims to find best PTSD screening for pregnant black women
Knowledge-focused Recruiting nowThis study compares two different screening methods for PTSD in 804 pregnant Black women. The goal is to see which approach better identifies PTSD symptoms, improves use of prenatal and mental health care, and leads to healthier births. Participants will be in their first trimest…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:52 UTC
-
New MRI technique may sharpen radiation targeting in Kids' brain cancer
Knowledge-focused Recruiting nowThis study tests whether a special type of MRI (spectroscopic MRI) can help doctors better target proton radiation therapy for children with aggressive brain tumors. The MRI maps tumor metabolism without needing a contrast injection. Researchers will check if this approach improv…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:51 UTC
-
Can a simple pill or bike riding fix exercise troubles in kidney disease?
Knowledge-focused Recruiting nowThis study looks at why people with chronic kidney disease (CKD) have trouble exercising and why their blood pressure spikes during activity. Researchers will test if regular bike exercise, a drug called Kuvan, or amino acid supplements can help. The goal is to understand the bod…
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:50 UTC
-
Kidney Patients' exercise struggles under the microscope
Knowledge-focused Recruiting nowThis study looks at why people with chronic kidney disease (CKD) have trouble exercising and why their blood pressure rises during activity. Researchers will measure muscle oxygen and pH levels in 110 veterans with and without CKD. The goal is to understand the body's response, n…
Phase: PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:50 UTC
-
Healthy volunteers inhale flu virus to unlock secrets of infection
Knowledge-focused Recruiting nowThis study intentionally gives healthy adults a mild flu infection to learn how the immune system fights the virus and how the virus spreads. Researchers will monitor symptoms and safety closely. The goal is to gather knowledge, not to test a treatment or vaccine.
Phase: PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:49 UTC
-
New registry to monitor Real-World effects of Alzheimer's drugs
Knowledge-focused Recruiting nowThis study collects information from 735 Alzheimer's patients aged 50-90 who are receiving FDA-approved anti-amyloid antibody treatments. Researchers will track changes in memory, thinking, and daily living skills over time. The goal is to understand how well these drugs work in …
Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 06:48 UTC
-
Can a blood pressure drug lower heart risk in PTSD?
Knowledge-focused Recruiting nowThis study looks at why people with PTSD have a higher chance of heart disease and high blood pressure. Researchers want to understand what causes high adrenaline levels during stress in PTSD patients. They will also test if a medicine called losartan can lower these adrenaline l…
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC
-
New study investigates link between body composition and cystic fibrosis health
Knowledge-focused Recruiting nowThis study looks at how the amount of muscle and fat in the body affects health in people with cystic fibrosis (CF) aged 16 to 30. Researchers will measure body fat distribution, lung function, and blood sugar control in 60 people with CF and 30 healthy volunteers. The goal is to…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC